Welcome to The Lost Debata Show for Politically Ecclectics. I'm Robbie Gupta, and today I welcome on Neil Shaw, Dr. Neil Shaw, who is the chief medical officer at Maven Clinic, which is the largest virtual clinic for women's and family health, and a visiting scientist at Harvard Medical School. He's the co-founder of Marsh for Moms Association, a coalition of more than 20 leading organizations dedicated to increasing

public and private investment in the well-being of mothers. He's also the founder of Cost for Care

and NGO that curates insights from clinicians and patients to help delivery systems to provide

better health care. He has written books. He's been a commentator. He's listening to this

podcast. Just a quick

heads up that you'll hear a siren and some backrun noise here and there during this recording, but it shouldn't be too distracting. Neil, welcome. Thank you, Ravi. I've more than listened to the podcast. I've been a fan of viewers for a while, so I'm excited to be in conversations. It's our first time meeting. Likewise, man.

And I'm a big fan of the work at Maven.

And you and I are talking to be in conversations. It's our first time meeting. Likewise, man. And I'm a big fan of the work at Maven.

And you and I are talking just for our audience's benefit the day before the election. But we're going to air this after the election. So we're going to sidestep the like who's going to win and, you know, sizing up the two candidates and point ahead to the deeper issues in our health care system

that no matter who wins, we hope that whoever wins this election, sizing up the two candidates and point ahead to the deeper issues in our health care system

that no matter who wins, we hope that whoever wins this election is going to be focused on.

So it will be a little bit of wishcasting here.

But why don't we start with the big question I've been grappling with on this podcast for a while,

and you know I've talked to a lot of people about this.

And it's just like sizing up the U.S. healthcare system as a whole, if you were like a visiting scholar from like Norway or something and you're like, okay, I'm going to just do a write-up on what works and what doesn't work in the U.S. healthcare system at a broad level,

how would you assess where we are?

From the perspective of the visiting scholar from Norway.

Yeah, it doesn't have to be Norway, but just anybody who's just like, I mean, I think

American exceptionalism is very present in healthcare.

So one way that I think about it is that I think that

Sloan Kettering and M.D. Anderson are uniquely American institutions. And if you have a really rare

form of small cell lung cancer, if you're a person who may benefit from a proton beam for treatment

...